Peter D. Wilson

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

P. Vasey, Stan B. Kaye, Rachel Morrison et al. · PubMed · 1999 · 691 citations

Pathology, Pharmacotherapy, Maximum Tolerated Dose +16

RNA Mango Aptamer-Fluorophore: A Bright, High-Affinity Complex for RNA Labeling and Tracking

Elena V. Dolgosheina, Sunny C.Y. Jeng, S. Panchapakesan et al. · ACS Chemical Biology · 2014 · 439 citations

Rna Labeling, Rna Mango, Engineering +15

Total Hip Replacement with Fixation by Acrylic Cement

Peter D. Wilson, H C Amstutz, A. Czerniecki et al. · Journal of Bone and Joint Surgery · 1972 · 177 citations

Skeletal Trauma, Hip Arthroplasty, Skeletal Fixation +13

The Use of Perineal Ultrasound to Quantify Levator Activity and Teach Pelvic Floor Muscle Exercises

Hans Peter Dietz, Peter D. Wilson, B. Clarke · International Urogynecology Journal · 2001 · 174 citations

Medical Ultrasound, Kinesiology, Pelvic Floor Disorders +11

Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer

P. D. Peppercorn, R H Reznek, Peter D. Wilson et al. · British Journal of Cancer · 1998 · 168 citations · Full text

Gastroenterology, Pathology, Advanced Colorectal Cancer +16